Portfolio Companies

A public cardiovascular and inflammatory disease company.

(NASDAQ: ANTH)

A private company rapidly advancing transformative therapies for patients with life threatening viral diseases.

A public company focused on targeted cancer therapeutics which was acquired by Merck & Co.

(NASDAQ: ARQL)

A private company developing novel drugs for inflammatory and immune diseases

A public company focused on optimizing the combination of proven cancer therapies which was acquired by Jazz Pharmaceuticals.

                                                            (NASDAQ: CPXX)

A private company developing the hormone, Relaxin, in acute heart failure - acquired by Novartis, originally Corthera

A private company focused on cancer therapeutics - acquired by Cephalon (now TEVA Pharmaceuticals).

A public Italian company treating vascular complications of cancer treatment (originally obtained as Gentium, acquired by Jazz Pharmaceuticals).

A public company whose products enable less invasive surgery using proprietary photonic solutions. Acquired by Stryker Corporation.

(NASDAQ: IVTY)

A public cancer therapeutics company with two molecules in development involved in immune responses to cancer.

(NASDAQ: LPTX)

A public company focused on use of aptamers for reversible treatments in acute care cardiovascular markets (acquired as Regado Biosciences, now Tobira Therapeutics).

(NASDAQ: TBRA)

A public company focused on cancer therapeutics.

(NASDAQ: SNSS)

 A public company focused on insomnia.

(NASDAQ: TSPT)

A public company primarily focused on treatments for obesity and diabetes.

(NASDAQ: VVUS)